pyridostigmine bromide has been researched along with Red-Cell Aplasia, Pure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aquilina, A; Aquilina, J; Camilleri, DJ | 1 |
| Ayats, R; Bordes, R; Illa, I; López, R; Montserrat, I; Sardà, P | 1 |
2 other study(ies) available for pyridostigmine bromide and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
Pure red cell aplasia and myasthenia gravis: a patient having both autoimmune conditions in the absence of thymoma.
Topics: Aged; Blood Component Transfusion; Cholinesterase Inhibitors; Humans; Immunoglobulins, Intravenous; Male; Myasthenia Gravis; Pyridostigmine Bromide; Red-Cell Aplasia, Pure; Thymectomy; Thymoma; Treatment Outcome | 2017 |
[Erythroblastopenia during recurrence of a thymoma associated with myasthenia gravis. Apropos of a new case].
Topics: Aged; Antigens, CD; Autoimmune Diseases; Cells, Cultured; Cholinesterase Inhibitors; Combined Modality Therapy; Erythroid Precursor Cells; Female; Humans; Immunophenotyping; Myasthenia Gravis; Neoplasm Recurrence, Local; Pyridostigmine Bromide; Red-Cell Aplasia, Pure; T-Lymphocyte Subsets; Thymoma; Thymus Neoplasms | 1996 |